127 related articles for article (PubMed ID: 30241696)
1. Comparing the Detection of Endogenous Psychedelics in Individuals With and Without Alleged Mediumistic Experiences.
Vinhosa Bastos MA; Haidamus de Oliveira Bastos PR; Dos Santos ML; Iandoli D; Boschi Portella R; Lucchetti G
Explore (NY); 2018 Nov; 14(6):448-452. PubMed ID: 30241696
[TBL] [Abstract][Full Text] [Related]
2. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
Forsström T; Tuominen J; Karkkäinen J
Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
[TBL] [Abstract][Full Text] [Related]
3. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
Barker SA; McIlhenny EH; Strassman R
Drug Test Anal; 2012; 4(7-8):617-35. PubMed ID: 22371425
[TBL] [Abstract][Full Text] [Related]
4. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.
Kärkkäinen J; Forsström T; Tornaeus J; Wähälä K; Kiuru P; Honkanen A; Stenman UH; Turpeinen U; Hesso A
Scand J Clin Lab Invest; 2005; 65(3):189-99. PubMed ID: 16095048
[TBL] [Abstract][Full Text] [Related]
5. Gas chromatographic-mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites.
Sitaram BR; Lockett L; McLeish M; Hayasaka Y; Blackman GL; McLeod WR
J Chromatogr; 1987 Nov; 422():13-23. PubMed ID: 3481368
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
Riba J; McIlhenny EH; Bouso JC; Barker SA
Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
[TBL] [Abstract][Full Text] [Related]
7. Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders.
Takeda N; Ikeda R; Ohba K; Kondo M
Neuroreport; 1995 Nov; 6(17):2378-80. PubMed ID: 8747157
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
9. Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
Emanuele E; Colombo R; Martinelli V; Brondino N; Marini M; Boso M; Barale F; Politi P
Neuro Endocrinol Lett; 2010; 31(1):117-21. PubMed ID: 20150873
[TBL] [Abstract][Full Text] [Related]
10. Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine.
Räisänen M; Kärkkäinen J
J Chromatogr; 1979 Apr; 162(4):579-84. PubMed ID: 118980
[No Abstract] [Full Text] [Related]
11. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
[TBL] [Abstract][Full Text] [Related]
12. Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia.
Pomilio AB; Vitale AA; Ciprian-Ollivier J; Cetkovich-Bakmas M; Gómez R; Vázquez G
J Ethnopharmacol; 1999 Apr; 65(1):29-51. PubMed ID: 10350367
[TBL] [Abstract][Full Text] [Related]
13. Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography.
Riceberg LJ; Vunakis HV
J Pharmacol Exp Ther; 1978 Jul; 206(1):158-66. PubMed ID: 275476
[TBL] [Abstract][Full Text] [Related]
14. [Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].
Matsumoto H; Pietruszewska I
Psychiatr Pol; 1978; 12(2):189-97. PubMed ID: 275869
[No Abstract] [Full Text] [Related]
15. Testing alleged mediumship: methods and results.
O'keeffe C; Wiseman R
Br J Psychol; 2005 May; 96(Pt 2):165-79. PubMed ID: 15969829
[TBL] [Abstract][Full Text] [Related]
16. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
[No Abstract] [Full Text] [Related]
17. A bufotenin-like substance in the urine of schizophrenics.
Cottrell AC; Mcleod MF; Mcleod WR
Am J Psychiatry; 1977 Mar; 134(3):322-2. PubMed ID: 265142
[No Abstract] [Full Text] [Related]
18. Syrian rue seeds interacted with acacia tree bark in an herbal stew resulted in N,N-dimethyltryptamine poisoning.
Liu CH; Chu WL; Liao SC; Yang CC; Lin CC
Clin Toxicol (Phila); 2019 Oct; 57(10):867-869. PubMed ID: 30831037
[No Abstract] [Full Text] [Related]
19. A test of the transmethylation hypothesis in acute schizophrenic patients.
Carpenter WT; Fink EB; Narasimhachari N; Himwich HE
Am J Psychiatry; 1975 Oct; 132(10):1067-71. PubMed ID: 1058643
[TBL] [Abstract][Full Text] [Related]
20. Harmala Alkaloids Identify Ayahausca Intoxication in a Urine Drug Screen.
Pope JD; Choy KW; Drummer OH; Schneider HG
J Anal Toxicol; 2019 May; 43(4):e23-e27. PubMed ID: 30566569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
